SITC is a premier event where experts in the field of cancer research present cutting-edge studies.
SITC is a premier event where experts in the field of cancer research present cutting-edge studies.
Connecting life science executives, strategics & investors.
Alloplex CEO, Dr. Frank Borriello is a speaker within the emerging cell-based immunotherapies section.
Alloplex CEO, Dr. Frank Borriello is a speaker within the Gamma Delta Immunotherapy Track.
Alloplex CEO, Dr. Borriello to attend and participate in round table discussions in the 'new cellular modalities' track.
Alloplex presents a poster describing the clinical update of SUPLEXA Therapeutic Cells in Patients.
The AACR Special Conference on Tumor Immunology and Immunotherapy is designed to broaden our understanding of ways to harness the immune system to treat cancer.
Dr. Frank Borriello will deliver an oral presentation at the Immuno-Oncology Summit 2022 in Boston, MA
Presentation by Dr. Lederer on 23 August
Dr. Borriello & Dr. James Lederer speak on ‘Reviewing the clinical safety and efficacy of gamma delta therapies’
Dr. Frank Borriello presented as the keynote speaker at the Annual Markets and Markets' Next Gen Immuno-Oncology Conference.
Alloplex presents poster describing novel tumor-killing cells at SITC 2021 Conference.
The AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Alloplex's Dr. Frank Borriello will be highlighting the differentiation of the Alloplex oncology therapy at Roth’s Capital Partners’ Virtual Healthcare Private Company Forum.
Dr. Borriello has been selected as a VIP Speaker at Sir Anthony Ritossa's 15th Anniversary Global Family Office Investment Summit.
Dr Frank Borriello participates on panel
Dr Frank Borriello took part in a panel discussion entitled Paradigm-shifting Platforms: Taking Immuno-Oncology to the Next Level.
Dr Frank Borriello participates on panel
Dr Frank Borriello presents corporate overview
American Society of Clinical Oncology Annual Meeting